Veterinary Medicines

Aftopur DOE

Authorised
  • Foot-and-mouth disease virus, serotype O, Inactivated
  • Foot-and-mouth disease virus, serotype A, Inactivated
  • Foot-and-mouth disease virus, serotype C, Inactivated
  • Foot-and-mouth disease virus, serotype Asia 1, Inactivated
  • Foot-and-mouth disease virus, serotype SAT 1, Inactivated
  • Foot-and-mouth disease virus, serotype SAT 2, Inactivated
  • Foot-and-mouth disease virus, serotype SAT 3, Inactivated
Download as PDF

Product identification

Medicine name:
Aftopur DOE Homogenous cream opaque double oil emulsion for injection
Aftopur DOE
Active substance:
  • Foot-and-mouth disease virus, serotype O, Inactivated
  • Foot-and-mouth disease virus, serotype A, Inactivated
  • Foot-and-mouth disease virus, serotype C, Inactivated
  • Foot-and-mouth disease virus, serotype Asia 1, Inactivated
  • Foot-and-mouth disease virus, serotype SAT 1, Inactivated
  • Foot-and-mouth disease virus, serotype SAT 2, Inactivated
  • Foot-and-mouth disease virus, serotype SAT 3, Inactivated
Target species:
  • Cattle
  • Pig
  • Sheep
  • Goat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Foot-and-mouth disease virus, serotype O, Inactivated
    3.00
    microgram(s)
    /
    1.00
    millilitre(s)
  • Foot-and-mouth disease virus, serotype A, Inactivated
    3.00
    microgram(s)
    /
    1.00
    millilitre(s)
  • Foot-and-mouth disease virus, serotype C, Inactivated
    3.00
    microgram(s)
    /
    1.00
    millilitre(s)
  • Foot-and-mouth disease virus, serotype Asia 1, Inactivated
    3.00
    microgram(s)
    /
    1.00
    millilitre(s)
  • Foot-and-mouth disease virus, serotype SAT 1, Inactivated
    3.00
    microgram(s)
    /
    1.00
    millilitre(s)
  • Foot-and-mouth disease virus, serotype SAT 2, Inactivated
    3.00
    microgram(s)
    /
    1.00
    millilitre(s)
  • Foot-and-mouth disease virus, serotype SAT 3, Inactivated
    3.00
    microgram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AA04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • (ID1) 20 millilitre(s): Box (Cardboard) with 1 Bottle (PolyPropylene) with 20 millilitre(s)
  • (ID2) 50 millilitre(s): Box (Cardboard) with 1 Bottle (PolyPropylene) with 50 millilitre(s)
  • (ID5) 300 millilitre(s): Box (Cardboard) with 1 Bottle (PolyPropylene) with 300 millilitre(s)
  • (ID4) 200 millilitre(s): Box (Cardboard) with 1 Bottle (PolyPropylene) with 200 millilitre(s)
  • (ID3) 100 millilitre(s): Box (Cardboard) with 1 Bottle (PolyPropylene) with 100 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 04491/3003
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0285/001
Concerned member states:
  • United Kingdom (Northern Ireland)